Skip to content

Ketamine: all studies

Page 376 of 449: studies 3,751 to 3,760 of 4,490, newest first. Back to the ketamine overview

Research

High Rates of Drug Use and Chemsex Among PrEP Users and People with HIV in Milan Highlight Need for Targeted Interventions.

AIDS and behavior June 9, 2025 Chiara Fusetti, Enrico Caruso, Andrea Giacomelli et al. 2 citations

Chemsex, the use of psychostimulant substances during sexual activity particularly among men who have sex with men (MSM), is a growing public health concern. This study aimed to assess drug use, engagement in chemsex, and related knowledge among pre-exposure prophylaxis (PrEP) users and people with HIV (PWH) attending two sexually transmitted infection (STI) services in Milan, Italy. An...

Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.

Molecular Neurobiology June 4, 2025 Naser-Aldin Lashgari, Mahla Khalaji, Pouria Rana et al. 7 citations

Neurological and psychiatric disorders are considered one of the major problems of today's societies and cause many individual and social problems. Current treatments are effective, but due to their burdens, there is always an effort to introduce novel treatments. Psychedelics, a diverse group of psychoactive compounds, including LSD, psilocybin, DMT, MDMA, and ketamine, have shown potential in...

DOI: 10.1007/s12035-025-05097-9 (opens in new tab) Full text (opens in new tab) Neurologic diseases Novel therapeutic approaches Oxidative stress Psychiatric disorders +8

Fixed dose combination dextromethorphan-bupropion: A hope for treatment resistant depression (TRD).

Indian Journal of Psychiatry June 1, 2025 Ranjan Das, Rajarshi Chakravarty, Varaha V Gantait et al. 4 citations

Treatment resistant depression (TRD) has been identified as non-response to depression with adequate dose and trial of two antidepressant medications of different classes. Near about 30% depressive patients are TRD cases. Olanzapine-fluoxetine combination, rTMS, Intravenous ketamine and Electroconvulsive therapy have been till now studied in TRD. Dextromethorphan-bupropion is a newer...

DOI: 10.4103/indianjpsychiatry_315_25 (opens in new tab) Full text (opens in new tab) Dextromethorphan-bupropion Treatment resistant depression Severe depression New approach +2

Evaluation of spectroscopic techniques for on-site drug testing of festival seizures.

Drug Testing and Analysis June 1, 2025 N Meert, J Eliaerts, F Van Durme et al. 8 citations

Despite the fact that drugs of abuse are illegal, a drug-free festival still remains an utopia in most settings. For law enforcement purposes, it is necessary to rapidly determine whether controlled substances are involved. On-site testing is a challenging task because drugs appear in different physical forms and concentrations. The aim of this study was to compare the performance of two...

DOI: 10.1002/dta.3780 (opens in new tab) Full text (opens in new tab) Raman Chemometrics Drug seizures Infrared +6

Zebrafish embryo-larval testing reveals differential toxicity of new psychoactive substances.

Toxicology Reports June 1, 2025 Leonardo Costalonga Rodrigues, Alexandre Barcia de Godoi, Viviane Cristina Fais et al. 4 citations

New psychoactive substances (NPS) have emerged as a significant public health concern, with synthetic cannabinoid receptor agonists (SCRAs) and ketamine derivatives being among the most frequently detected compounds in the forensic context worldwide. The Fish Embryo Acute Toxicity (FET) and Maximum Tolerated Concentration (MTC) tests are used to evaluate the acute toxicity of chemicals. In this...

DOI: 10.1016/j.toxrep.2025.102018 (opens in new tab) Full text (opens in new tab) Maximum tolerated concentration New psychoactive substances Zebrafish embryos Developmental toxicity +2

Neural mass modelling of brain stimulation to Alleviate Schizophrenia biomarkers in brain rhythms.

Computers in biology and medicine June 1, 2025 Swapna Sasi, Basabdatta Sen Bhattacharya, Vanteemar S Sreeraj et al.

We present a neural mass model (NMM) of the brain thalamo-cortico-thalamic (TCT) network to understand the effectiveness of non-invasive treatment with transcranial Direct Current Stimulation (tDCS) in reversing the anomalous electroencephalogram (EEG) oscillations in Schizophrenia. Our TCT NMM consists of twelve neural populations representing the thalamus and cortex modules of the visual...

DOI: 10.1016/j.compbiomed.2025.110190 (opens in new tab) Full text (opens in new tab) EEG Brain Rhythms Neural mass models Thalamocortical Neurological disorders +3

Implementation of a multimodal pain protocol in adult burn patients.

Burns : journal of the International Society for Burn Injuries June 1, 2025 Alyssa Garelli, Allison N Boyd, Michelle Brown et al. 2 citations

The 2020 American Burn Association guidelines recommend a multimodal approach to pain management comprised of both opioids and non-opioids. The purpose of this study was to compare outcomes before and after implementation of a multimodal pain order set in the burn admission order set within the electronic medical record. This single center, retrospective, cohort study was conducted at an...

DOI: 10.1016/j.burns.2025.107515 (opens in new tab) Full text (opens in new tab) Acute pain Burns Multimodal pain Pain management +4

Advances in the study of NMDA receptors in depression pathogenesis and the antidepressant efficacy of their antagonists.

Asian Journal of Psychiatry June 1, 2025 Mingrui Chen, Jingyan Jin, Hongsheng Bi et al. 12 citations

N-methyl-D-aspartate receptors (NMDA receptors) play a crucial role as ionotropic glutamate receptors in regulating neuroplasticity, learning, memory, and a range of psychiatric disorders. Studies indicate that dysfunction of NMDA receptors is a key pathological mechanism in depression, where abnormal activation can result in neuronal excitotoxicity, excessive extracellular calcium ion...

DOI: 10.1016/j.ajp.2025.104502 (opens in new tab) Full text (opens in new tab) Antidepressants Glutamatergic Nmda receptor antagonists Nmda receptors +4

Perception of Pain in the Catheter Angiography Laboratory Among Children with Congenital Heart Disease.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir June 1, 2025 Serdar Kula, Daniiar Amatov, Akif Kavgacı et al.

This study aimed to evaluate the level of pain caused by routine procedures during cardiac catheterization and explore ways to enhance patient comfort during the procedure based on the findings. The study involved 24 pediatric patients with congenital heart disease who underwent cardiac catheterization at our center. Pain perception was assessed using skin conductance activity, a non-invasive...

DOI: 10.5543/tkda.2025.69934 (opens in new tab) Full text (opens in new tab) Pediatric cardiology Pain management Anesthesia Cardiac catheterization +1

Exploring the Effects of Ketofol and Etomidate on Cerebral Blood Flow and Oxygenation during Anesthesia Induction in Supratentorial Tumor Patients: A Randomized Double-Blind Study.

Asian journal of neurosurgery June 1, 2025 Siddharth Chakraborty, Priyanka Gupta, Sharmishtha Pathak et al.

Objectives During anesthesia induction, fluctuations in systemic hemodynamic may also alter cerebral hemodynamic, especially in patients with intracranial tumors, as these patients might have impaired cerebral autoregulation. This study compared the effects of ketofol (a mixture of ketamine and propofol) and etomidate on cerebral blood flow, oxygenation, and systemic hemodynamics during...

DOI: 10.1055/s-0045-1804530 (opens in new tab) Full text (opens in new tab) Craniotomy Etomidate Ketofol Regional cerebral oxygenation +5